CNTG
Closed
Centogene B V
0.1531
+0.0107 (+7.51%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 0.1424
Day's Range: 0.1531 - 0.1531
Send
sign up or login to leave a comment!
When Written:
0.6539
Centogene B.V. is a global biotech company that specializes in genetic testing and diagnostics. The company was founded in 2006 and is headquartered in Rostock, Germany, with additional offices in Berlin, Germany, and Cambridge, Massachusetts, USA.
Centogene offers a variety of genetic testing services, including whole exome sequencing, targeted gene panels, and carrier testing. The company also provides genetic counseling services and clinical trial support for rare diseases.
Centogene has partnerships with pharmaceutical companies, academic institutions, and healthcare providers around the world. The company's goal is to improve the diagnosis and treatment of rare diseases by providing accurate and timely genetic testing services.
In 2020, Centogene became one of the first companies to offer COVID-19 testing, including PCR and antibody testing. The company's COVID-19 testing services are available for individuals, healthcare providers, and businesses.
Centogene is publicly traded on the NASDAQ stock exchange under the ticker symbol CNTG.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Centogene offers a variety of genetic testing services, including whole exome sequencing, targeted gene panels, and carrier testing. The company also provides genetic counseling services and clinical trial support for rare diseases.
Centogene has partnerships with pharmaceutical companies, academic institutions, and healthcare providers around the world. The company's goal is to improve the diagnosis and treatment of rare diseases by providing accurate and timely genetic testing services.
In 2020, Centogene became one of the first companies to offer COVID-19 testing, including PCR and antibody testing. The company's COVID-19 testing services are available for individuals, healthcare providers, and businesses.
Centogene is publicly traded on the NASDAQ stock exchange under the ticker symbol CNTG.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








